European Developments in the Environmental Risk Assessment of Pharmaceuticals

  • J. Koschorreck
  • S. Hickmann

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. EC (2001a) Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products. Official journal N° L 311/67Google Scholar
  2. EC (2001b) Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to human medicinal products. Official journal N° L 311/1Google Scholar
  3. EC (2001c) European Commission Directorate Health and Consumer Protection – Scientific Committee on Toxicity, Ecotoxicity and the Environment Opinion on: Draft CPMP Discussion Paper on Environmental Risk Assessment of Medicinal Products for Human Use [Non-Genetically Modified Organism (Non-GMO) Containing]. Report, Nr C2/JCD/csteeop/CPMPpaperRAssessHum Pharm12062001/D(01)Google Scholar
  4. EEC (1980) Council Directive 80/68/EEC of 17 December 1979 on the protection of groundwater against pollution caused by certain dangerous substances. Official journal N° L 020Google Scholar
  5. EEC (1981) Council Directive 81/851/EEC of 28 September 1981 on the approximation of the laws of the Member States relating to veterinary medicinal products. Official journal N° L 317Google Scholar
  6. EEC (1993) Council Directive 93/39/EEC of 14 June 1993 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC in respect of medicinal products. Official journal N° L 214Google Scholar
  7. EEC (1995) Environmental Risk Assessment for Human Medicinal Products Containing or Consisting of GMOs. European Agency for the Evaluation of Medicinal Products, London, UK (Report no. EMEA/ CPMP/III/5507/94)Google Scholar
  8. EMEA (1997) Environmental risk assessment for veterinary medicinal products other than gmo-containing and immunological products. European Agency for the Evaluation of Medicinal Products, London, UK (Report no. EMEA/CVMP/055/96)Google Scholar
  9. EMEA (1998) Note for Guidance: Environmental risk assessment for veterinary medicinal products other than GMO-containing and immunological products. European AgenGoogle Scholar
  10. EMEA (2001) Discussion paper on environmental risk assessment of non-genetically modified organisms (non gmo) containing medicinal products for human use. European Agency for the Evaluation of Medicinal Products, London, UK (Report no. CPMP/SWP/4447/00draft corr)Google Scholar
  11. EMEA (2003) Note for guidance on environmental risk assessment for products of human use. European Agency for the Evaluation of Medicinal Products, London, UK (Report no. CPMP/SWP/4447/ 00draft)Google Scholar
  12. EMEA (2005) Guideline on the environmental impact assessment of medicinal products for human use. European Agency for the Evaluation of Medicinal Products, London, UK (Report no. CPMP/SWP/ 4447/00 draft)Google Scholar
  13. EMEA (2006) Guideline on the environmental impact assessment of medicinal products for human use. European Agency for the Evaluation of Medicinal Products, London, UK (Report no. CPMP/SWP/ 4447/00)Google Scholar
  14. EMEA (2007) Environmental impact assessment for veterinary medicinal products in support of the VICH guidelines GL6 (Phase I) and GL38 (Phase II). European Agency for the Evaluation of Medicinal Products, London, UK (Report no. EMEA/CVMP/ERA/418282/2005-corr)Google Scholar
  15. EU (2003) Technical Guidance Document in support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. EUR 20418 EN/1. European Chemicals Bureau, Ispra, ItalyGoogle Scholar
  16. FDA (1997) Retrospective review of ecotoxicity data submitted in environmental assessments for public display. Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (Docket No. 96N-0057)Google Scholar
  17. FDA (1998) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), CMC 6 - Revision 1Google Scholar
  18. VICH (2000) VICH Topic GL6 (Ecotoxicity Phase I) Step 7 Guideline on Environmental Impact Assessment (EIAs) for Veterinary Medicinal Products – Phase I. European Agency for the Evaluation of Medicinal Products, London, UK (Report no. CVMP/VICH/592/98)Google Scholar
  19. VICH (2004) Guideline on environmental impact assessment for veterinary medicinal products Phase II. European Agency for the Evaluation of Medicinal Products, London, UK (Report no. CVMP/VICH/ 790/03-FINA)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • J. Koschorreck
    • 1
  • S. Hickmann
    • 2
  1. 1.UmweltbundesamtGermany
  2. 2.UmweltbundesamtGermany

Personalised recommendations